The current report unraveled a new mechanism of As3+ carcinogenesis, which suggests that As3+ is inhibitory for the tumor suppressor-like character of AHR, followed by the amplification of the oncogenic pathways of TGFβ, Nrf2 and others. The gene discussed is TGFB1; the disease is neoplasm.